160 related articles for article (PubMed ID: 19942681)
1. Overexpression of RAD51 suppresses recombination defects: a possible mechanism to reverse genomic instability.
Schild D; Wiese C
Nucleic Acids Res; 2010 Mar; 38(4):1061-70. PubMed ID: 19942681
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional homologous recombination mediates genomic instability and progression in myeloma.
Shammas MA; Shmookler Reis RJ; Koley H; Batchu RB; Li C; Munshi NC
Blood; 2009 Mar; 113(10):2290-7. PubMed ID: 19050310
[TBL] [Abstract][Full Text] [Related]
3. Recombination and its roles in DNA repair, cellular immortalization and cancer.
Shammas MA; Shmookler Reis RJ
Age (Omaha); 1999 Apr; 22(2):71-88. PubMed ID: 23604399
[TBL] [Abstract][Full Text] [Related]
4. Statement of Retraction: Molecular Dissection of Interactions between Rad51 and Members of the Recombination-Repair.
Mol Cell Biol; 2024; 44(6):259. PubMed ID: 38845150
[No Abstract] [Full Text] [Related]
5. RAD51AP1-deficiency in vertebrate cells impairs DNA replication.
Parplys AC; Kratz K; Speed MC; Leung SG; Schild D; Wiese C
DNA Repair (Amst); 2014 Dec; 24():87-97. PubMed ID: 25288561
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis.
Wang YY; Cheng KH; Hung AC; Lo S; Chen PY; Wu YC; Hou MF; Yuan SF
Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38063232
[TBL] [Abstract][Full Text] [Related]
7. RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma.
Tsai YF; Chan LP; Chen YK; Su CW; Hsu CW; Wang YY; Yuan SF
Cancer Cell Int; 2023 Oct; 23(1):231. PubMed ID: 37798649
[TBL] [Abstract][Full Text] [Related]
8. SOSSB1 and SOSSB2 mutually regulate protein stability through competitive binding of SOSSA.
Zhang Q; Hao R; Chen H; Zhou G
Cell Death Discov; 2023 Aug; 9(1):319. PubMed ID: 37640700
[TBL] [Abstract][Full Text] [Related]
9. Retroperitoneal leiomyosarcoma in a female patient with a germline splicing variant RAD51D c.904-2A > T: a case report.
Futagawa M; Yamamoto H; Kochi M; Urakawa Y; Sogawa R; Kato F; Okazawa-Sakai M; Ennishi D; Shinozaki K; Inoue H; Yanai H; Hirasawa A
Hered Cancer Clin Pract; 2021 Nov; 19(1):48. PubMed ID: 34838098
[TBL] [Abstract][Full Text] [Related]
10. CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy.
Sun H; Zhou R; Zheng Y; Wen Z; Zhang D; Zeng D; Wu J; Huang Z; Rong X; Huang N; Sun L; Bin J; Liao Y; Shi M; Liao W
Oncogene; 2021 Aug; 40(34):5342-5355. PubMed ID: 34262130
[TBL] [Abstract][Full Text] [Related]
11. Epigenomic Analysis of RAD51 ChIP-seq Data Reveals
Kang K; Choi Y; Moon H; You C; Seo M; Kwon G; Yun J; Beck B; Kang K
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34067336
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.
Moustafa D; Elwahed MRA; Elsaid HH; Parvin JD
PLoS One; 2021; 16(1):e0235025. PubMed ID: 33412559
[TBL] [Abstract][Full Text] [Related]
13. Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition.
Makino E; Fröhlich LM; Sinnberg T; Kosnopfel C; Sauer B; Garbe C; Schittek B
Cell Death Dis; 2020 Jul; 11(7):581. PubMed ID: 32719412
[TBL] [Abstract][Full Text] [Related]
14. PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes.
Owens JL; Beketova E; Liu S; Tinsley SL; Asberry AM; Deng X; Huang J; Li C; Wan J; Hu CD
iScience; 2020 Jan; 23(1):100750. PubMed ID: 31884170
[TBL] [Abstract][Full Text] [Related]
15. E2F1 facilitates DNA break repair by localizing to break sites and enhancing the expression of homologous recombination factors.
Choi EH; Kim KP
Exp Mol Med; 2019 Sep; 51(9):1-12. PubMed ID: 31534120
[TBL] [Abstract][Full Text] [Related]
16. Gene Ontology and Expression Studies of Strigolactone Analogues on a Hepatocellular Carcinoma Cell Line.
Hasan MN; Razvi SS; Choudhry H; Hassan MA; Moselhy SS; Kumosani TA; Zamzami MA; Abualnaja KO; Halwani MA; Al-Malki AL; Ragoussis J; Wu W; Bronner C; Asami T; Alhosin M
Anal Cell Pathol (Amst); 2019; 2019():1598182. PubMed ID: 31482051
[TBL] [Abstract][Full Text] [Related]
17. The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers.
Marzio A; Puccini J; Kwon Y; Maverakis NK; Arbini A; Sung P; Bar-Sagi D; Pagano M
Mol Cell; 2019 Jan; 73(2):224-237.e6. PubMed ID: 30554948
[TBL] [Abstract][Full Text] [Related]
18. Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.
Chernikova SB; Nguyen RB; Truong JT; Mello SS; Stafford JH; Hay MP; Olson A; Solow-Cordero DE; Wood DJ; Henry S; von Eyben R; Deng L; Gephart MH; Aroumougame A; Wiese C; Game JC; Győrffy B; Brown JM
J Clin Invest; 2018 Dec; 128(12):5307-5321. PubMed ID: 30371505
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis.
Ruíz G; Valencia-González HA; León-Galicia I; García-Villa E; García-Carrancá A; Gariglio P
Stem Cells Int; 2018; 2018():2493869. PubMed ID: 29681946
[TBL] [Abstract][Full Text] [Related]
20. The impact of the IGF-1 system of cancer cells on radiation response - An
Venkatachalam S; Mettler E; Fottner C; Miederer M; Kaina B; Weber MM
Clin Transl Radiat Oncol; 2017 Dec; 7():1-8. PubMed ID: 29594222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
